17 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35060921 | Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. | 2022 Feb 3 | 1 |
2 | 35624740 | The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature. | 2022 Apr 29 | 1 |
3 | 32698689 | Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. | 2021 Oct | 1 |
4 | 32957884 | Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview. | 2021 | 1 |
5 | 33444408 | Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study. | 2021 | 1 |
6 | 33459225 | Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections. | 2021 | 2 |
7 | 33520683 | Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection. | 2021 Mar | 1 |
8 | 33847382 | Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro. | 2021 Dec | 1 |
9 | 34574194 | Consumption of Phenolic-Rich Food and Dietary Supplements as a Key Tool in SARS-CoV-19 Infection. | 2021 Sep 3 | 1 |
10 | 34607208 | In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals. | 2021 Dec | 1 |
11 | 34824739 | Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease. | 2021 Summer | 1 |
12 | 34931597 | In silico study of potential immunonutrient-based sports supplements against COVID-19 via targeting ACE2 inhibition using molecular docking and molecular dynamics simulations. | 2021 Dec 21 | 1 |
13 | 32593613 | Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. | 2020 Aug | 2 |
14 | 32643448 | Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. | 2020 Aug | 2 |
15 | 32656311 | Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. | 2020 Jun | 2 |
16 | 33179911 | Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity. | 2020 Nov 25 | 2 |
17 | 33200026 | Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. | 2020 | 3 |